Vylor (NYSE:VYLR) Raised to “Hold” at BNP Paribas Exane

Vylor (NYSE:VYLR) was upgraded by investment analysts at BNP Paribas Exane to a “hold” rating in a report released on Wednesday, Zacks reports.

A number of other equities research analysts have also recently commented on VYLR. Oppenheimer initiated coverage on Vylor in a research note on Tuesday, October 6th. They issued an “outperform” rating and a $82.00 target price on the stock. Mizuho began coverage on Vylor in a research report on Monday, October 5th. They issued an “outperform” rating and a $84.00 price target for the company. BMO Capital Markets initiated coverage on Vylor in a research report on Friday, October 2nd. They issued an “outperform” rating and a $85.00 price target for the company. Morgan Stanley initiated coverage on shares of Vylor in a research note on Friday, October 2nd. They issued an “overweight” rating and a $85.00 price target on the stock. Finally, Bank of America initiated coverage on shares of Vylor in a research note on Monday, October 5th. They issued a “buy” rating and a $78.00 price target on the stock. Three equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $82.67.

Vylor Stock Down 3.3%

VYLR stock opened at $74.42 on Wednesday. Vylor has a twelve month low of $65.00 and a twelve month high of $77.39.

About Vylor

Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.